Skip to content

Clinical trials

Phase 1/2 Lymphoma, T-Cell, Peripheral trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Phase: Phase 1/2 Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20061
20071
20083
20091
20111
20133
20141
20151
20161
20182
20192
20201
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated7
Recruiting3
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
AbbVie (prior sponsor, Abbott)1
Acrotech Biopharma Inc.1
Aileron Therapeutics, Inc.1
Asana BioSciences1
AstraZeneca1
Bristol-Myers Squibb1
CellCentric Ltd.1
Columbia University1
Conjupro Biotherapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral24
Lymphoma, Non-Hodgkin13
Lymphoma, Follicular11
Hodgkin Disease10
Lymphoma, Large B-Cell, Diffuse10
Lymphoma, Large-Cell, Anaplastic10
Lymphoma, Mantle-Cell10
Lymphoma9
Lymphoma, B-Cell, Marginal Zone9
Leukemia, Lymphocytic, Chronic, B-Cell8

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.